Neuronetrix
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Neuronetrix sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
Neuronetrix: 4 sponsored US clinical trials, 1 recruiting.
Neuronetrix sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Healthy, with 1 trials.
Upper-quartile sponsor footprint
Neuronetrix sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Normative QEEG/ERP Data for Healthy Volunteers
NCT05869032
EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
NCT02769234
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
NCT00938665
Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
NCT00582127
Therapeutic Areas
What is open in the Neuronetrix pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Healthy (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.